Sectors

Evidation, co-founded by Stanford University and GE Ventures, has picked up series E funding at a $1bn valuation.

The gene therapy developer focused on cardiovascular and central nervous system diseases will merge with Chardan Healthcare Acquisition 2 Corp to list on NYSE.

The Tencent-backed online sports app operator’s latest secondary round valued it at nearly $5bn, though the identity of the sellers has not been disclosed.

The SoftBank and Alibaba-backed sports memorabilia retailer doubled its valuation to $12.8bn in a late-stage round that took its total funding near the $2bn mark.

The Alphabet, Virgin and Access Industries-backed cryptocurrency technology provider hiked its valuation to $5.2bn in a series C announced just five weeks after its last round.

The event community platform developer secured the series C funding at a $325m valuation and plans to more than double headcount this year.

Stuart Therapeutics has collected equity financing from investors including Wisconsin Alumni Research Foundation to fund phase 2 trials for a drug aimed at dry eye disease.

First American Financial and Shea Ventures contributed to a round that reportedly made the second-hand home marketplace the fastest US company so far to achieve unicorn status.

The Petronas and TNSC-backed 3D printing tedchnology provider has agreed to list through a reverse takeover deal at a $1.6bn valuation.

Citi’s strategic investment vehicle helped fill out a series D round valuing the risk management software developer above $1bn.

The WuXi AppTec-backed infectious disease therapeutics developer has closed a series C round featuring various investment managers and Singapore's sovereign wealth fund.